Drugdiscovery >> Clinical Trials >> News
3391
Views
N30 Pharma starts a new trial for oral cystic fibrosis drug - drugdiscovery.com
N30 Pharma starts a new trial for oral cystic fibrosis drug - drugdiscovery.com


N30 Phamra started the phase I clinical trial of N9115, a new cystic fibrosis drug.The study is randomized, placebo-controlled, double-blind and reached its final cohort.
Read More >>


Tags: Clinical Trial,Cystic Fibrosis, Drugs, Fibrosis, Gene, Genetic, Pharmacokinetics, Placebo, Protein - March 13, 2014
Related Articles
5514
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

3394
Views
Novel oral agent beneficial for pulmonary arterial hypertension Novel oral agent beneficial for pulmonary arterial hypertension
Actelion’s drug Opsumit (macitentan), a novel dual endothelin-receptor antagonist has been successful in improving clinical outcomes in patients with pulmonary arterial hypertension (PAH) in the SE Read More >>

Tags: Actelion, opsumit, macitentan, endothelin-receptor antagonist, pulmonary arterial hypertension, PAH, SERAPHIN, clinical trial, new treatment, drug

7984
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

3100
Views
New Lymphoma Trial was announced in the UK New Lymphoma Trial was announced in the UK
The body’s own immune system is going to be used for treating Lymphoma in the new method; the clinical trial of which was announced by Cancer Research UK’s Drug Development Office. The body's own Read More >>

Tags: B-cells, ancer Research UK’s Drug Development Office, immune system, Lymphoma, clinical trial

2136
Views
MediciNova’s drug MN-166 heads to trial for alcohol dependence MediciNova’s drug MN-166 heads to trial for alcohol dependence
MediciNova Inc. a biopharmaceutical company, announced that the National Institute on Alcohol Abuse and Alcoholism will fund a clinical trial of its drug MN-166 (ibudilast) for alcohol addiction. The Read More >>

Tags: MN-166, ibudilast, alcohol, addiction, methamphetamine, opioid, dependence, clinical trial, MediciNova

7538
Views
Mallinckrodt's pain drug successful in Phase 3 clinical trial Mallinckrodt's pain drug successful in Phase 3 clinical trial
The experimental pain drug MNK-795 met the primary endpoint of a Phase 3 study, improving the pain scores, compared to placebo, in patients with acute pain after surgery. Read More >>

Tags: pain drug, MNK-795, clinical trial, Mallinckrodt

5191
Views
New Alzheimer drug enters Phase 3 program New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different Read More >>

Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial

7030
Views
Special Protocol Assessment  for a Phase 3 clinical trial of antibiotic plazomicin Special Protocol Assessment for a Phase 3 clinical trial of antibiotic plazomicin
Plazomicin is a next-generation aminoglycoside antibiotic engineered by Achaogen. It has potent bactericidal activity against important gram-negative pathogens, including carbapenem-resistant Enteroba Read More >>

Tags: plazomicin, antibiotic, aminoglycoside antibiotic, next generation, Achaogen, gram-negative, CRE, clinical trial, multi-drug resistant, MDR, bacterial infections

6862
Views
A global Phase 3 clinical trial for Alzheimer’s disease to be lounched A global Phase 3 clinical trial for Alzheimer’s disease to be lounched
Takeda and Zinfandel have announced the initiation of TOMMORROW Phase 3 clinical trial which will investigate a genetic-based biomarker risk assignment algorithm for the predicition of the risk of mil Read More >>

Tags: clinical trial, global, Alzheimer’s disease, Takeda, Zinfandel, risk assignment algorithm, cognitive impairment risk, pioglitazone, investigational drug

1374
Views
Phase III trial of Amgen's drug was an outstanding success Phase III trial of Amgen's drug was an outstanding success
Evolocumab, the new drug of Amgen has gone through Phase III. clinical trial. The result is a statistically significant reduction in low-density lipoprotein cholesterol. The new drug seems to be 66% m Read More >>

Tags: drug, competitior, cholesterol, Amgen

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013